Search

Your search keyword '"Weiss, Jonathan"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Weiss, Jonathan" Remove constraint Author: "Weiss, Jonathan" Journal blood Remove constraint Journal: blood
19 results on '"Weiss, Jonathan"'

Search Results

1. Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial

2. Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA

3. The GATA-3–dependent transcriptome and tumor microenvironment are regulated by eIF4E and XPO1 in T-cell lymphomas

4. Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy

5. Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism

6. Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-Sequencing

8. B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide

9. Long-Term Remissions with MRD-Guided Acalabrutinib, Venetoclax and Obinutuzumab in Relapsed/Refractory CLL: Follow-up Efficacy and Circulating Tumor DNA Analysis of the CLL2-Baag Trial

10. MRD-Guided Zanubrutinib, Venetoclax and Obinutuzumab after an Optional Debulking with Bendamustine in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Primary Endpoint Analysis of the Phase 2 CLL2-Bzag Study

12. The GATA-3–dependent transcriptome and tumor microenvironment are regulated by eIF4E and XPO1 in T-cell lymphomas

13. KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) — Pharmacodynamics and Updated Results

14. Mechanisms of Venetoclax Resistance in Chronic Lymphocytic Leukemia

15. A Selective and Potent Rock 2 Inhibitor (KD025) Decreases Human STAT3-Dependent IL-21 and IL-17 Production and Experimental Chronic Graft-Versus-Host Disease (cGVHD)

17. Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA

18. Delineation of antigen-specific and antigen-nonspecific CD8+memory T-cell responses after cytokine-based cancer immunotherapy

19. Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy.

Catalog

Books, media, physical & digital resources